Biologics now most common treatment for children with systemic juvenile idiopathic arthritis; excellent results in many
New research presented this week at ACR Convergence, the American College of Rheumatology's annual meeting, shows that biologics were the most common initial treatment prescribed to treat systemic juvenile idiopathic arthritis ...
Nov 1, 2021
0
2